State of Alaska Department of Revenue Reduces Stock Position in U.S. Physical Therapy, Inc. (NYSE:USPH)

State of Alaska Department of Revenue cut its holdings in shares of U.S. Physical Therapy, Inc. (NYSE:USPH) by 2.2% during the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 8,364 shares of the company’s stock after selling 189 shares during the quarter. State of Alaska Department of Revenue owned approximately 0.06% of U.S. Physical Therapy worth $605,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently bought and sold shares of the business. CBIZ Investment Advisory Services LLC grew its position in shares of U.S. Physical Therapy by 59.8% in the 4th quarter. CBIZ Investment Advisory Services LLC now owns 326 shares of the company’s stock worth $29,000 after acquiring an additional 122 shares in the last quarter. Point72 Asia Singapore Pte. Ltd. acquired a new position in U.S. Physical Therapy during the 4th quarter valued at approximately $39,000. Fifth Third Bancorp boosted its position in U.S. Physical Therapy by 34.6% during the 1st quarter. Fifth Third Bancorp now owns 1,030 shares of the company’s stock valued at $75,000 after purchasing an additional 265 shares during the period. Lazard Asset Management LLC acquired a new position in U.S. Physical Therapy during the 4th quarter valued at approximately $84,000. Finally, Aquatic Capital Management LLC boosted its position in U.S. Physical Therapy by 18.0% during the 4th quarter. Aquatic Capital Management LLC now owns 1,298 shares of the company’s stock valued at $115,000 after purchasing an additional 198 shares during the period.

Insider Buying and Selling at U.S. Physical Therapy

In other news, Director Nancy Ham sold 400 shares of the stock in a transaction that occurred on Thursday, June 12th. The stock was sold at an average price of $78.01, for a total value of $31,204.00. Following the completion of the sale, the director now directly owns 2,594 shares of the company’s stock, valued at approximately $202,357.94. This represents a 13.36% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Corporate insiders own 2.00% of the company’s stock.

U.S. Physical Therapy Stock Up 0.6%

USPH opened at $79.13 on Friday. U.S. Physical Therapy, Inc. has a fifty-two week low of $62.77 and a fifty-two week high of $101.20. The business has a 50-day moving average of $74.89 and a 200-day moving average of $79.95. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.17 and a quick ratio of 1.17. The company has a market capitalization of $1.20 billion, a PE ratio of 36.30, a price-to-earnings-growth ratio of 3.83 and a beta of 1.45.

U.S. Physical Therapy (NYSE:USPH) last issued its quarterly earnings data on Wednesday, May 7th. The company reported $0.48 EPS for the quarter, beating analysts’ consensus estimates of $0.46 by $0.02. U.S. Physical Therapy had a return on equity of 7.89% and a net margin of 4.57%. The business had revenue of $183.79 million for the quarter, compared to analyst estimates of $176.78 million. During the same quarter in the prior year, the firm posted $0.51 EPS. The firm’s revenue for the quarter was up 18.0% on a year-over-year basis. Equities research analysts forecast that U.S. Physical Therapy, Inc. will post 2.67 EPS for the current fiscal year.

U.S. Physical Therapy Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, June 13th. Shareholders of record on Friday, May 23rd were issued a dividend of $0.45 per share. The ex-dividend date of this dividend was Friday, May 23rd. This represents a $1.80 annualized dividend and a yield of 2.27%. U.S. Physical Therapy’s dividend payout ratio (DPR) is presently 82.57%.

Analyst Upgrades and Downgrades

Several analysts have weighed in on the company. JPMorgan Chase & Co. cut their target price on U.S. Physical Therapy from $120.00 to $110.00 and set an “overweight” rating on the stock in a research note on Wednesday, March 19th. JMP Securities reaffirmed a “market outperform” rating and set a $113.00 target price on shares of U.S. Physical Therapy in a research note on Tuesday, April 22nd. Finally, Wall Street Zen raised U.S. Physical Therapy from a “sell” rating to a “hold” rating in a research note on Thursday, May 8th. Two equities research analysts have rated the stock with a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, U.S. Physical Therapy has a consensus rating of “Moderate Buy” and a consensus price target of $109.00.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.